Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   TEVA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
TEVA PHARMA
Dec-13
DR. REDDYS LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,6563,479-   
Low Rs3,7883,022-   
Sales per share (Unadj.) Rs1,481.41,996.4-  
Earnings per share (Unadj.) Rs270.7124.7-  
Cash flow per share (Unadj.) Rs345.7286.1-  
Dividends per share (Unadj.) Rs40.00109.18-  
Avg Dividend yield %0.93.4 28.2%  
Book value per share (Unadj.) Rs1,389.62,217.6-  
Shares outstanding (eoy) m166.53848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.81.6 175.0%   
Avg P/E ratio x15.626.1 59.9%  
P/CF ratio (eoy) x12.211.4 107.5%  
Price / Book Value ratio x3.01.5 207.3%  
Dividend payout %14.887.5 16.9%   
Avg Mkt Cap Rs m703,0392,756,220 25.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m46,4660-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m246,6971,692,969 14.6%  
Other income Rs m10,5550-   
Total revenues Rs m257,2521,692,969 15.2%   
Gross profit Rs m63,860463,620 13.8%  
Depreciation Rs m12,502136,844 9.1%   
Interest Rs m1,42833,253 4.3%   
Profit before tax Rs m60,485293,523 20.6%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m15,412-3,584 -430.1%   
Profit after tax Rs m45,073105,758 42.6%  
Gross profit margin %25.927.4 94.5%  
Effective tax rate %25.5-1.2 -2,087.0%   
Net profit margin %18.36.2 292.5%  
BALANCE SHEET DATA
Current assets Rs m203,1611,143,425 17.8%   
Current liabilities Rs m85,721997,163 8.6%   
Net working cap to sales %47.68.6 551.0%  
Current ratio x2.41.1 206.7%  
Inventory Days Days7991 87.3%  
Debtors Days Days10796 111.8%  
Net fixed assets Rs m112,638552,961 20.4%   
Share capital Rs m8334,167 20.0%   
"Free" reserves Rs m230,5710-   
Net worth Rs m231,4041,880,567 12.3%   
Long term debt Rs m1,278865,653 0.1%   
Total assets Rs m315,7993,868,976 8.2%  
Interest coverage x43.49.8 441.2%   
Debt to equity ratio x00.5 1.2%  
Sales to assets ratio x0.80.4 178.5%   
Return on assets %14.73.6 409.8%  
Return on equity %19.55.6 346.4%  
Return on capital %26.64.9 539.6%  
Exports to sales %52.20-   
Imports to sales %16.80-   
Net fx Rs m87,3190-   
CASH FLOW
From Operations Rs m58,875269,772 21.8%  
From Investments Rs m-41,373-95,591 43.3%  
From Financial Activity Rs m-26,861-323,609 8.3%  
Net Cashflow Rs m-9,073-149,429 6.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare DR. REDDYS LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare DR. REDDYS LAB With: SMS PHARMA  NEULAND LABS  IPCA LABS  GENNEX LAB.  TRIDENT LIFELINE  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.